Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer

Go back to Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer
(NASDAQ: IMUX) Delayed: 9.37 -1.47 (13.56%)
Previous Close $10.84    52 Week High
Open $10.85    52 Week Low
Day High $11.12    P/E N/A 
Day Low $9.36    EPS
Volume 662,159